Uenami, T., Ishijima, M., Kanazu, M., Kurebe, H., Edahiro, R., Nishida, K., . . . Mori, M. (2018). Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression. Ann Transl Med.
Dyfyniad Arddull ChicagoUenami, Takeshi, et al. "Two Cases of Response to Pembrolizumab in Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma Patients With Programmed Death-ligand 1 Overexpression." Ann Transl Med 2018.
Dyfyniad MLAUenami, Takeshi, et al. "Two Cases of Response to Pembrolizumab in Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma Patients With Programmed Death-ligand 1 Overexpression." Ann Transl Med 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.